nodes	percent_of_prediction	percent_of_DWPC	metapath
Memantine—CYP2A6—Formoterol—chronic obstructive pulmonary disease	0.153	0.238	CbGbCtD
Memantine—CYP2A6—Arformoterol—chronic obstructive pulmonary disease	0.153	0.238	CbGbCtD
Memantine—CYP2A6—Montelukast—chronic obstructive pulmonary disease	0.116	0.18	CbGbCtD
Memantine—CYP2A6—Prednisolone—chronic obstructive pulmonary disease	0.0679	0.106	CbGbCtD
Memantine—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0632	0.0984	CbGbCtD
Memantine—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0632	0.0984	CbGbCtD
Memantine—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0265	0.0413	CbGbCtD
Memantine—CYP2A6—NRF2 pathway—SOD3—chronic obstructive pulmonary disease	0.000273	0.00547	CbGpPWpGaD
Memantine—GRIN2B—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00027	0.00542	CbGpPWpGaD
Memantine—DRD2—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	0.000269	0.0054	CbGpPWpGaD
Memantine—CYP2C19—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000257	0.00516	CbGpPWpGaD
Memantine—CYP2B6—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000251	0.00503	CbGpPWpGaD
Memantine—CYP2A6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000247	0.00495	CbGpPWpGaD
Memantine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000245	0.00492	CbGpPWpGaD
Memantine—CYP2B6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000242	0.00486	CbGpPWpGaD
Memantine—HTR3A—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000242	0.00485	CbGpPWpGaD
Memantine—CYP2C19—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000241	0.00484	CbGpPWpGaD
Memantine—GRIN2A—Alzheimers Disease—IL1B—chronic obstructive pulmonary disease	0.000236	0.00473	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—LEP—chronic obstructive pulmonary disease	0.000234	0.00469	CbGpPWpGaD
Memantine—SLC22A2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000231	0.00463	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—TLR4—chronic obstructive pulmonary disease	0.000229	0.0046	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000228	0.00456	CbGpPWpGaD
Memantine—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000221	0.00443	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000219	0.00438	CbGpPWpGaD
Memantine—CYP2A6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000218	0.00437	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—NOS2—chronic obstructive pulmonary disease	0.000218	0.00437	CbGpPWpGaD
Memantine—CYP2C19—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000215	0.0043	CbGpPWpGaD
Memantine—GRIN1—Alzheimers Disease—IL1B—chronic obstructive pulmonary disease	0.000206	0.00412	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000201	0.00404	CbGpPWpGaD
Memantine—GRIN2B—Alzheimers Disease—IL1B—chronic obstructive pulmonary disease	0.0002	0.00402	CbGpPWpGaD
Memantine—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000199	0.00399	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000195	0.00391	CbGpPWpGaD
Memantine—CYP2A6—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	0.000194	0.0039	CbGpPWpGaD
Memantine—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000192	0.000622	CcSEcCtD
Memantine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000191	0.000618	CcSEcCtD
Memantine—CYP2C19—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00019	0.0038	CbGpPWpGaD
Memantine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000189	0.000614	CcSEcCtD
Memantine—SLC22A2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000188	0.00377	CbGpPWpGaD
Memantine—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000188	0.00061	CcSEcCtD
Memantine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000187	0.000607	CcSEcCtD
Memantine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000187	0.000607	CcSEcCtD
Memantine—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000187	0.000607	CcSEcCtD
Memantine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000186	0.000604	CcSEcCtD
Memantine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000186	0.000604	CcSEcCtD
Memantine—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000186	0.000603	CcSEcCtD
Memantine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000186	0.000602	CcSEcCtD
Memantine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000186	0.00372	CbGpPWpGaD
Memantine—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000185	0.000601	CcSEcCtD
Memantine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000185	0.000599	CcSEcCtD
Memantine—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000184	0.000598	CcSEcCtD
Memantine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000184	0.000596	CcSEcCtD
Memantine—CYP2C19—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000183	0.00367	CbGpPWpGaD
Memantine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000183	0.000593	CcSEcCtD
Memantine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000183	0.000593	CcSEcCtD
Memantine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000183	0.000592	CcSEcCtD
Memantine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000183	0.000592	CcSEcCtD
Memantine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000181	0.000588	CcSEcCtD
Memantine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000181	0.000588	CcSEcCtD
Memantine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00018	0.000585	CcSEcCtD
Memantine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00018	0.000584	CcSEcCtD
Memantine—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000179	0.000582	CcSEcCtD
Memantine—CYP2A6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000179	0.00359	CbGpPWpGaD
Memantine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000179	0.00058	CcSEcCtD
Memantine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000179	0.000579	CcSEcCtD
Memantine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000179	0.000579	CcSEcCtD
Memantine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000178	0.00358	CbGpPWpGaD
Memantine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000178	0.000578	CcSEcCtD
Memantine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000178	0.000578	CcSEcCtD
Memantine—CYP2A6—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.000178	0.00356	CbGpPWpGaD
Memantine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000177	0.000576	CcSEcCtD
Memantine—SLC22A2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000177	0.00355	CbGpPWpGaD
Memantine—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000177	0.000574	CcSEcCtD
Memantine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000177	0.000573	CcSEcCtD
Memantine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000176	0.000572	CcSEcCtD
Memantine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000176	0.000572	CcSEcCtD
Memantine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000176	0.000571	CcSEcCtD
Memantine—CYP2B6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000176	0.00353	CbGpPWpGaD
Memantine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000176	0.00057	CcSEcCtD
Memantine—Injury—Prednisone—chronic obstructive pulmonary disease	0.000175	0.000566	CcSEcCtD
Memantine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000174	0.000566	CcSEcCtD
Memantine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000174	0.000565	CcSEcCtD
Memantine—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000174	0.000563	CcSEcCtD
Memantine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000173	0.000561	CcSEcCtD
Memantine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000173	0.000561	CcSEcCtD
Memantine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000173	0.00056	CcSEcCtD
Memantine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000173	0.00056	CcSEcCtD
Memantine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000173	0.00056	CcSEcCtD
Memantine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000172	0.000559	CcSEcCtD
Memantine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000171	0.000556	CcSEcCtD
Memantine—Pain—Formoterol—chronic obstructive pulmonary disease	0.000171	0.000556	CcSEcCtD
Memantine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000171	0.000556	CcSEcCtD
Memantine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000171	0.000556	CcSEcCtD
Memantine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000171	0.000555	CcSEcCtD
Memantine—GRIN2A—Alzheimers Disease—TNF—chronic obstructive pulmonary disease	0.000171	0.00343	CbGpPWpGaD
Memantine—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000171	0.000554	CcSEcCtD
Memantine—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000171	0.000554	CcSEcCtD
Memantine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00017	0.000551	CcSEcCtD
Memantine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000169	0.000549	CcSEcCtD
Memantine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000169	0.000549	CcSEcCtD
Memantine—GRIN1—EPH-Ephrin signaling—MMP9—chronic obstructive pulmonary disease	0.000169	0.00338	CbGpPWpGaD
Memantine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000169	0.000547	CcSEcCtD
Memantine—CYP2A6—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.000168	0.00338	CbGpPWpGaD
Memantine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000168	0.000545	CcSEcCtD
Memantine—Pain—Montelukast—chronic obstructive pulmonary disease	0.000168	0.000544	CcSEcCtD
Memantine—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000168	0.000544	CcSEcCtD
Memantine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000167	0.000543	CcSEcCtD
Memantine—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000167	0.000541	CcSEcCtD
Memantine—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000167	0.000541	CcSEcCtD
Memantine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000167	0.00054	CcSEcCtD
Memantine—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000166	0.00054	CcSEcCtD
Memantine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000166	0.000538	CcSEcCtD
Memantine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000166	0.000538	CcSEcCtD
Memantine—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000165	0.000536	CcSEcCtD
Memantine—CYP2A6—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.000165	0.00331	CbGpPWpGaD
Memantine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000165	0.000535	CcSEcCtD
Memantine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000165	0.000535	CcSEcCtD
Memantine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000165	0.000535	CcSEcCtD
Memantine—GRIN2B—EPH-Ephrin signaling—MMP9—chronic obstructive pulmonary disease	0.000164	0.0033	CbGpPWpGaD
Memantine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000164	0.000533	CcSEcCtD
Memantine—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000164	0.000533	CcSEcCtD
Memantine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000164	0.000532	CcSEcCtD
Memantine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000164	0.000531	CcSEcCtD
Memantine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000164	0.000531	CcSEcCtD
Memantine—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000164	0.000531	CcSEcCtD
Memantine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000163	0.00053	CcSEcCtD
Memantine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000163	0.000529	CcSEcCtD
Memantine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000162	0.000525	CcSEcCtD
Memantine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000162	0.000525	CcSEcCtD
Memantine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00016	0.00052	CcSEcCtD
Memantine—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.00016	0.00052	CcSEcCtD
Memantine—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.00016	0.00052	CcSEcCtD
Memantine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000159	0.000516	CcSEcCtD
Memantine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000159	0.000516	CcSEcCtD
Memantine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000158	0.000514	CcSEcCtD
Memantine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000158	0.000514	CcSEcCtD
Memantine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000158	0.000514	CcSEcCtD
Memantine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000158	0.000514	CcSEcCtD
Memantine—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000158	0.000512	CcSEcCtD
Memantine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000158	0.000512	CcSEcCtD
Memantine—CYP2A6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000158	0.00316	CbGpPWpGaD
Memantine—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000157	0.000508	CcSEcCtD
Memantine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000157	0.000508	CcSEcCtD
Memantine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000156	0.000507	CcSEcCtD
Memantine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000156	0.000507	CcSEcCtD
Memantine—CYP2C19—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000156	0.00313	CbGpPWpGaD
Memantine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000156	0.000506	CcSEcCtD
Memantine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000156	0.000506	CcSEcCtD
Memantine—CYP2A6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000156	0.00312	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—CXCL8—chronic obstructive pulmonary disease	0.000156	0.00312	CbGpPWpGaD
Memantine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000156	0.000504	CcSEcCtD
Memantine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000155	0.000504	CcSEcCtD
Memantine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000155	0.000503	CcSEcCtD
Memantine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000155	0.000503	CcSEcCtD
Memantine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000155	0.000502	CcSEcCtD
Memantine—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000153	0.000498	CcSEcCtD
Memantine—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000153	0.000497	CcSEcCtD
Memantine—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000153	0.000495	CcSEcCtD
Memantine—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000153	0.000495	CcSEcCtD
Memantine—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000152	0.000493	CcSEcCtD
Memantine—GRIN1—EPH-Ephrin signaling—VEGFA—chronic obstructive pulmonary disease	0.000152	0.00304	CbGpPWpGaD
Memantine—GRIN2A—Alzheimers Disease—TP53—chronic obstructive pulmonary disease	0.000151	0.00302	CbGpPWpGaD
Memantine—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.00015	0.00302	CbGpPWpGaD
Memantine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00015	0.000487	CcSEcCtD
Memantine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00015	0.000485	CcSEcCtD
Memantine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00015	0.000485	CcSEcCtD
Memantine—HTR3A—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000149	0.003	CbGpPWpGaD
Memantine—GRIN1—Alzheimers Disease—TNF—chronic obstructive pulmonary disease	0.000149	0.00299	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—IL1B—chronic obstructive pulmonary disease	0.000149	0.00299	CbGpPWpGaD
Memantine—GRIN2B—EPH-Ephrin signaling—VEGFA—chronic obstructive pulmonary disease	0.000148	0.00296	CbGpPWpGaD
Memantine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000148	0.000479	CcSEcCtD
Memantine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000148	0.000479	CcSEcCtD
Memantine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000147	0.000478	CcSEcCtD
Memantine—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000147	0.000477	CcSEcCtD
Memantine—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000147	0.000477	CcSEcCtD
Memantine—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000146	0.000473	CcSEcCtD
Memantine—GRIN2B—Alzheimers Disease—TNF—chronic obstructive pulmonary disease	0.000145	0.00292	CbGpPWpGaD
Memantine—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000145	0.0029	CbGpPWpGaD
Memantine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000145	0.000469	CcSEcCtD
Memantine—SLC22A2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000144	0.00289	CbGpPWpGaD
Memantine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000144	0.000466	CcSEcCtD
Memantine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000144	0.000466	CcSEcCtD
Memantine—HTR3A—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000143	0.00288	CbGpPWpGaD
Memantine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000142	0.00046	CcSEcCtD
Memantine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000142	0.00046	CcSEcCtD
Memantine—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000459	CcSEcCtD
Memantine—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000459	CcSEcCtD
Memantine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000141	0.000457	CcSEcCtD
Memantine—GRIN1—Spinal Cord Injury—MMP9—chronic obstructive pulmonary disease	0.000141	0.00282	CbGpPWpGaD
Memantine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000139	0.000452	CcSEcCtD
Memantine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000139	0.00045	CcSEcCtD
Memantine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000137	0.000445	CcSEcCtD
Memantine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000137	0.000445	CcSEcCtD
Memantine—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000136	0.000442	CcSEcCtD
Memantine—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000136	0.000441	CcSEcCtD
Memantine—DRD2—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	0.000136	0.00272	CbGpPWpGaD
Memantine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000136	0.00044	CcSEcCtD
Memantine—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000438	CcSEcCtD
Memantine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000135	0.0027	CbGpPWpGaD
Memantine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000134	0.000435	CcSEcCtD
Memantine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000134	0.000434	CcSEcCtD
Memantine—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000133	0.00267	CbGpPWpGaD
Memantine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000132	0.00043	CcSEcCtD
Memantine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000132	0.00043	CcSEcCtD
Memantine—GRIN1—Alzheimers Disease—TP53—chronic obstructive pulmonary disease	0.000132	0.00264	CbGpPWpGaD
Memantine—CYP2A6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000131	0.00263	CbGpPWpGaD
Memantine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00013	0.000421	CcSEcCtD
Memantine—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.00013	0.00042	CcSEcCtD
Memantine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000129	0.00042	CcSEcCtD
Memantine—GRIN2B—Alzheimers Disease—TP53—chronic obstructive pulmonary disease	0.000128	0.00257	CbGpPWpGaD
Memantine—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000128	0.000414	CcSEcCtD
Memantine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000127	0.000413	CcSEcCtD
Memantine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000127	0.000413	CcSEcCtD
Memantine—CYP2B6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000127	0.00255	CbGpPWpGaD
Memantine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000126	0.00041	CcSEcCtD
Memantine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000126	0.00041	CcSEcCtD
Memantine—CYP2A6—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	0.000126	0.00253	CbGpPWpGaD
Memantine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000126	0.000409	CcSEcCtD
Memantine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000126	0.000409	CcSEcCtD
Memantine—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000126	0.000409	CcSEcCtD
Memantine—DRD2—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.000126	0.00253	CbGpPWpGaD
Memantine—CYP2B6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000126	0.00252	CbGpPWpGaD
Memantine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000126	0.000407	CcSEcCtD
Memantine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000126	0.000407	CcSEcCtD
Memantine—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000125	0.000407	CcSEcCtD
Memantine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000125	0.000406	CcSEcCtD
Memantine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000125	0.000406	CcSEcCtD
Memantine—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000125	0.000406	CcSEcCtD
Memantine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000125	0.000405	CcSEcCtD
Memantine—CYP2A6—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000125	0.0025	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000124	0.00249	CbGpPWpGaD
Memantine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000124	0.000401	CcSEcCtD
Memantine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000124	0.000401	CcSEcCtD
Memantine—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000123	0.0004	CcSEcCtD
Memantine—Depression—Prednisone—chronic obstructive pulmonary disease	0.000123	0.0004	CcSEcCtD
Memantine—DRD2—Circadian rythm related genes—SLC6A4—chronic obstructive pulmonary disease	0.000123	0.00247	CbGpPWpGaD
Memantine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000123	0.000399	CcSEcCtD
Memantine—CYP2A6—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.000123	0.00246	CbGpPWpGaD
Memantine—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000395	CcSEcCtD
Memantine—HTR3A—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000121	0.00243	CbGpPWpGaD
Memantine—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000393	CcSEcCtD
Memantine—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000393	CcSEcCtD
Memantine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00012	0.00039	CcSEcCtD
Memantine—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.00012	0.000389	CcSEcCtD
Memantine—GRIN1—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.00012	0.0024	CbGpPWpGaD
Memantine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000119	0.000387	CcSEcCtD
Memantine—GRIN1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000119	0.00239	CbGpPWpGaD
Memantine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000119	0.000387	CcSEcCtD
Memantine—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000119	0.000387	CcSEcCtD
Memantine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000119	0.000386	CcSEcCtD
Memantine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000119	0.000386	CcSEcCtD
Memantine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000119	0.000386	CcSEcCtD
Memantine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000119	0.000384	CcSEcCtD
Memantine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.000379	CcSEcCtD
Memantine—GRIN2B—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.000117	0.00234	CbGpPWpGaD
Memantine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000117	0.000378	CcSEcCtD
Memantine—GRIN1—Spinal Cord Injury—TGFB1—chronic obstructive pulmonary disease	0.000116	0.00232	CbGpPWpGaD
Memantine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000115	0.000374	CcSEcCtD
Memantine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000115	0.000372	CcSEcCtD
Memantine—CYP2A6—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000114	0.0023	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—EGFR—chronic obstructive pulmonary disease	0.000114	0.00228	CbGpPWpGaD
Memantine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000113	0.000366	CcSEcCtD
Memantine—DRD2—Circadian rythm related genes—ADIPOQ—chronic obstructive pulmonary disease	0.000113	0.00226	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—HDAC2—chronic obstructive pulmonary disease	0.000112	0.00225	CbGpPWpGaD
Memantine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000112	0.000364	CcSEcCtD
Memantine—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000112	0.000363	CcSEcCtD
Memantine—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000362	CcSEcCtD
Memantine—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000111	0.00036	CcSEcCtD
Memantine—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.00011	0.000358	CcSEcCtD
Memantine—CYP2A6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000109	0.00219	CbGpPWpGaD
Memantine—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000109	0.00219	CbGpPWpGaD
Memantine—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000354	CcSEcCtD
Memantine—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000109	0.000352	CcSEcCtD
Memantine—GRIN1—Spinal Cord Injury—TNF—chronic obstructive pulmonary disease	0.000108	0.00217	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000108	0.00216	CbGpPWpGaD
Memantine—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000107	0.000346	CcSEcCtD
Memantine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000106	0.000343	CcSEcCtD
Memantine—CYP2B6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000106	0.00212	CbGpPWpGaD
Memantine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000105	0.00034	CcSEcCtD
Memantine—CYP2B6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000104	0.00209	CbGpPWpGaD
Memantine—HTR3A—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	0.000104	0.00209	CbGpPWpGaD
Memantine—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000336	CcSEcCtD
Memantine—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000334	CcSEcCtD
Memantine—GRIN1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000101	0.00203	CbGpPWpGaD
Memantine—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000327	CcSEcCtD
Memantine—CYP2A6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.0001	0.00201	CbGpPWpGaD
Memantine—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.0001	0.000325	CcSEcCtD
Memantine—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	9.91e-05	0.000322	CcSEcCtD
Memantine—HTR3A—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	9.91e-05	0.00199	CbGpPWpGaD
Memantine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	9.81e-05	0.000318	CcSEcCtD
Memantine—Alopecia—Prednisone—chronic obstructive pulmonary disease	9.81e-05	0.000318	CcSEcCtD
Memantine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	9.74e-05	0.000316	CcSEcCtD
Memantine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	9.72e-05	0.000315	CcSEcCtD
Memantine—Malnutrition—Prednisone—chronic obstructive pulmonary disease	9.66e-05	0.000313	CcSEcCtD
Memantine—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	9.61e-05	0.00193	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—TP53—chronic obstructive pulmonary disease	9.54e-05	0.00191	CbGpPWpGaD
Memantine—CYP2A6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	9.52e-05	0.00191	CbGpPWpGaD
Memantine—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	9.5e-05	0.00191	CbGpPWpGaD
Memantine—Pain—Prednisolone—chronic obstructive pulmonary disease	9.28e-05	0.000301	CcSEcCtD
Memantine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	9.1e-05	0.000295	CcSEcCtD
Memantine—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	8.96e-05	0.000291	CcSEcCtD
Memantine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	8.94e-05	0.00029	CcSEcCtD
Memantine—Anaemia—Prednisone—chronic obstructive pulmonary disease	8.93e-05	0.00029	CcSEcCtD
Memantine—Agitation—Prednisone—chronic obstructive pulmonary disease	8.88e-05	0.000288	CcSEcCtD
Memantine—CYP2B6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.82e-05	0.00177	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	8.74e-05	0.00175	CbGpPWpGaD
Memantine—Malaise—Prednisone—chronic obstructive pulmonary disease	8.71e-05	0.000283	CcSEcCtD
Memantine—CYP2B6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	8.7e-05	0.00174	CbGpPWpGaD
Memantine—Vertigo—Prednisone—chronic obstructive pulmonary disease	8.68e-05	0.000281	CcSEcCtD
Memantine—Syncope—Prednisone—chronic obstructive pulmonary disease	8.66e-05	0.000281	CcSEcCtD
Memantine—GRIN1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	8.66e-05	0.00174	CbGpPWpGaD
Memantine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	8.62e-05	0.00028	CcSEcCtD
Memantine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	8.49e-05	0.000275	CcSEcCtD
Memantine—HTR3A—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	8.4e-05	0.00168	CbGpPWpGaD
Memantine—Convulsion—Prednisone—chronic obstructive pulmonary disease	8.37e-05	0.000271	CcSEcCtD
Memantine—SLC22A2—Metabolism—APIP—chronic obstructive pulmonary disease	8.34e-05	0.00167	CbGpPWpGaD
Memantine—Hypertension—Prednisone—chronic obstructive pulmonary disease	8.34e-05	0.00027	CcSEcCtD
Memantine—Myalgia—Prednisone—chronic obstructive pulmonary disease	8.22e-05	0.000267	CcSEcCtD
Memantine—Arthralgia—Prednisone—chronic obstructive pulmonary disease	8.22e-05	0.000267	CcSEcCtD
Memantine—DRD2—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	8.22e-05	0.00165	CbGpPWpGaD
Memantine—Anxiety—Prednisone—chronic obstructive pulmonary disease	8.2e-05	0.000266	CcSEcCtD
Memantine—Discomfort—Prednisone—chronic obstructive pulmonary disease	8.13e-05	0.000264	CcSEcCtD
Memantine—CYP2B6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	8.1e-05	0.00162	CbGpPWpGaD
Memantine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	7.99e-05	0.000259	CcSEcCtD
Memantine—CYP2B6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	7.99e-05	0.0016	CbGpPWpGaD
Memantine—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.99e-05	0.0016	CbGpPWpGaD
Memantine—DRD2—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	7.9e-05	0.00158	CbGpPWpGaD
Memantine—Oedema—Prednisone—chronic obstructive pulmonary disease	7.88e-05	0.000256	CcSEcCtD
Memantine—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	7.88e-05	0.00158	CbGpPWpGaD
Memantine—Infection—Prednisone—chronic obstructive pulmonary disease	7.83e-05	0.000254	CcSEcCtD
Memantine—Shock—Prednisone—chronic obstructive pulmonary disease	7.76e-05	0.000252	CcSEcCtD
Memantine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	7.73e-05	0.000251	CcSEcCtD
Memantine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	7.7e-05	0.00025	CcSEcCtD
Memantine—CYP2B6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.68e-05	0.00154	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—APIP—chronic obstructive pulmonary disease	7.66e-05	0.00154	CbGpPWpGaD
Memantine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	7.66e-05	0.000248	CcSEcCtD
Memantine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	7.62e-05	0.000247	CcSEcCtD
Memantine—CYP2B6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	7.58e-05	0.00152	CbGpPWpGaD
Memantine—Anorexia—Prednisone—chronic obstructive pulmonary disease	7.52e-05	0.000244	CcSEcCtD
Memantine—GRIN1—Developmental Biology—LEP—chronic obstructive pulmonary disease	7.44e-05	0.00149	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—LEP—chronic obstructive pulmonary disease	7.26e-05	0.00146	CbGpPWpGaD
Memantine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	7.18e-05	0.000233	CcSEcCtD
Memantine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	7.17e-05	0.000233	CcSEcCtD
Memantine—Insomnia—Prednisone—chronic obstructive pulmonary disease	7.13e-05	0.000231	CcSEcCtD
Memantine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	7.08e-05	0.00023	CcSEcCtD
Memantine—DRD2—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	7.01e-05	0.00141	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	6.99e-05	0.0014	CbGpPWpGaD
Memantine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	6.94e-05	0.000225	CcSEcCtD
Memantine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	6.85e-05	0.000222	CcSEcCtD
Memantine—Rash—Prednisolone—chronic obstructive pulmonary disease	6.84e-05	0.000222	CcSEcCtD
Memantine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	6.83e-05	0.000222	CcSEcCtD
Memantine—Fatigue—Prednisone—chronic obstructive pulmonary disease	6.8e-05	0.00022	CcSEcCtD
Memantine—Headache—Prednisolone—chronic obstructive pulmonary disease	6.8e-05	0.00022	CcSEcCtD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	6.77e-05	0.00136	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	6.76e-05	0.00135	CbGpPWpGaD
Memantine—Constipation—Prednisone—chronic obstructive pulmonary disease	6.74e-05	0.000219	CcSEcCtD
Memantine—DRD2—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	6.73e-05	0.00135	CbGpPWpGaD
Memantine—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.66e-05	0.00134	CbGpPWpGaD
Memantine—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.57e-05	0.00132	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	6.53e-05	0.00131	CbGpPWpGaD
Memantine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	6.5e-05	0.000211	CcSEcCtD
Memantine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	6.45e-05	0.000209	CcSEcCtD
Memantine—Nausea—Prednisolone—chronic obstructive pulmonary disease	6.44e-05	0.000209	CcSEcCtD
Memantine—GRIN1—Axon guidance—MMP9—chronic obstructive pulmonary disease	6.27e-05	0.00126	CbGpPWpGaD
Memantine—Urticaria—Prednisone—chronic obstructive pulmonary disease	6.26e-05	0.000203	CcSEcCtD
Memantine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	6.23e-05	0.000202	CcSEcCtD
Memantine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	6.23e-05	0.000202	CcSEcCtD
Memantine—CYP2B6—Metabolism—APIP—chronic obstructive pulmonary disease	6.18e-05	0.00124	CbGpPWpGaD
Memantine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	6.18e-05	0.00124	CbGpPWpGaD
Memantine—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.12e-05	0.00123	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—MMP9—chronic obstructive pulmonary disease	6.11e-05	0.00123	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	6.05e-05	0.00121	CbGpPWpGaD
Memantine—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.04e-05	0.00121	CbGpPWpGaD
Memantine—HTR3A—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.95e-05	0.00119	CbGpPWpGaD
Memantine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	5.81e-05	0.000188	CcSEcCtD
Memantine—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.8e-05	0.00116	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	5.76e-05	0.00116	CbGpPWpGaD
Memantine—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.72e-05	0.00115	CbGpPWpGaD
Memantine—Asthenia—Prednisone—chronic obstructive pulmonary disease	5.66e-05	0.000183	CcSEcCtD
Memantine—GRIN1—Axon guidance—VEGFA—chronic obstructive pulmonary disease	5.63e-05	0.00113	CbGpPWpGaD
Memantine—Pruritus—Prednisone—chronic obstructive pulmonary disease	5.58e-05	0.000181	CcSEcCtD
Memantine—SLC22A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.53e-05	0.00111	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	5.5e-05	0.0011	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—VEGFA—chronic obstructive pulmonary disease	5.49e-05	0.0011	CbGpPWpGaD
Memantine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	5.39e-05	0.000175	CcSEcCtD
Memantine—SLC22A2—Metabolism—GC—chronic obstructive pulmonary disease	5.38e-05	0.00108	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	5.29e-05	0.00106	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	5.23e-05	0.00105	CbGpPWpGaD
Memantine—Dizziness—Prednisone—chronic obstructive pulmonary disease	5.21e-05	0.000169	CcSEcCtD
Memantine—DRD2—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	5.16e-05	0.00103	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.07e-05	0.00102	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—EGFR—chronic obstructive pulmonary disease	5.07e-05	0.00102	CbGpPWpGaD
Memantine—SLC22A2—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	5.06e-05	0.00102	CbGpPWpGaD
Memantine—Vomiting—Prednisone—chronic obstructive pulmonary disease	5.01e-05	0.000163	CcSEcCtD
Memantine—SLC22A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5e-05	0.001	CbGpPWpGaD
Memantine—Rash—Prednisone—chronic obstructive pulmonary disease	4.97e-05	0.000161	CcSEcCtD
Memantine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	4.97e-05	0.000161	CcSEcCtD
Memantine—Headache—Prednisone—chronic obstructive pulmonary disease	4.94e-05	0.00016	CcSEcCtD
Memantine—GRIN2B—Axon guidance—EGFR—chronic obstructive pulmonary disease	4.94e-05	0.00099	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GC—chronic obstructive pulmonary disease	4.94e-05	0.00099	CbGpPWpGaD
Memantine—Nausea—Prednisone—chronic obstructive pulmonary disease	4.68e-05	0.000152	CcSEcCtD
Memantine—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	4.67e-05	0.000936	CbGpPWpGaD
Memantine—CYP2A6—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	4.67e-05	0.000936	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	4.64e-05	0.000931	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	4.61e-05	0.000924	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.59e-05	0.00092	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—MMP9—chronic obstructive pulmonary disease	4.47e-05	0.000897	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—MMP9—chronic obstructive pulmonary disease	4.36e-05	0.000875	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.29e-05	0.00086	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	4.22e-05	0.000846	CbGpPWpGaD
Memantine—DRD2—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	4.11e-05	0.000825	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.09e-05	0.000821	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	4.08e-05	0.000818	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	4.03e-05	0.000808	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	4.02e-05	0.000806	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GC—chronic obstructive pulmonary disease	3.98e-05	0.000798	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	3.92e-05	0.000785	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—IL6—chronic obstructive pulmonary disease	3.89e-05	0.000781	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—IL6—chronic obstructive pulmonary disease	3.8e-05	0.000761	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.7e-05	0.000742	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	3.69e-05	0.000739	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—EGFR—chronic obstructive pulmonary disease	3.62e-05	0.000725	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	3.59e-05	0.000721	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—EGFR—chronic obstructive pulmonary disease	3.52e-05	0.000707	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—TNF—chronic obstructive pulmonary disease	3.44e-05	0.00069	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—TNF—chronic obstructive pulmonary disease	3.36e-05	0.000673	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.33e-05	0.000668	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	3.27e-05	0.000656	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.09e-05	0.00062	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.09e-05	0.00062	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.07e-05	0.000615	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	3.01e-05	0.000603	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.94e-05	0.000589	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.91e-05	0.000584	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GCLC—chronic obstructive pulmonary disease	2.9e-05	0.000582	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	2.86e-05	0.000573	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.8e-05	0.000561	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—IL6—chronic obstructive pulmonary disease	2.78e-05	0.000557	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—IL6—chronic obstructive pulmonary disease	2.71e-05	0.000543	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.7e-05	0.000541	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GCLC—chronic obstructive pulmonary disease	2.67e-05	0.000534	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CTGF—chronic obstructive pulmonary disease	2.65e-05	0.000531	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.65e-05	0.00053	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	2.62e-05	0.000525	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.6e-05	0.000522	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.57e-05	0.000516	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.49e-05	0.0005	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.49e-05	0.000499	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.44e-05	0.000489	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CTGF—chronic obstructive pulmonary disease	2.43e-05	0.000488	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.36e-05	0.000474	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.28e-05	0.000457	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.24e-05	0.000449	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.23e-05	0.000447	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.18e-05	0.000436	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	2.15e-05	0.000431	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.07e-05	0.000415	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.04e-05	0.000408	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.01e-05	0.000403	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.96e-05	0.000393	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.87e-05	0.000375	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.87e-05	0.000375	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.84e-05	0.00037	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.82e-05	0.000365	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.81e-05	0.000363	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.77e-05	0.000356	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.72e-05	0.000344	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.69e-05	0.00034	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.64e-05	0.00033	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.63e-05	0.000326	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.62e-05	0.000326	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.56e-05	0.000313	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.52e-05	0.000304	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.51e-05	0.000302	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.49e-05	0.000298	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	1.48e-05	0.000297	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.41e-05	0.000282	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.4e-05	0.00028	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.39e-05	0.000278	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.37e-05	0.000274	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.31e-05	0.000263	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.28e-05	0.000256	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.27e-05	0.000255	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.22e-05	0.000245	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ALB—chronic obstructive pulmonary disease	1.21e-05	0.000242	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.15e-05	0.000231	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.14e-05	0.000228	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.14e-05	0.000228	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.12e-05	0.000225	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ALB—chronic obstructive pulmonary disease	1.11e-05	0.000222	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—NOS3—chronic obstructive pulmonary disease	1.06e-05	0.000212	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.05e-05	0.00021	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.93e-06	0.000199	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	9.34e-06	0.000187	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	8.93e-06	0.000179	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.91e-06	0.000179	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	8.54e-06	0.000171	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.51e-06	0.000171	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.55e-06	0.000151	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.18e-06	0.000144	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.83e-06	0.000137	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	6.75e-06	0.000135	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	6.45e-06	0.000129	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.13e-06	0.000123	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.63e-06	0.000113	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.52e-06	0.000111	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.63e-06	9.29e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.24e-06	8.5e-05	CbGpPWpGaD
